Unknown

Dataset Information

0

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.


ABSTRACT: Lung disease caused by Mycobacterium abscessus is increasing, and current clarithromycin-based treatment regimens are only moderately effective. Here, we determined the effect of clarithromycin-vancomycin combination against M. abscessus complex isolates in vitro Synergy was found with a fractional inhibitory concentration index (FICI) score of ?0.5 and a 4- to 10-fold decrease in MIC.

SUBMITTER: Mukherjee D 

PROVIDER: S-EPMC5700366 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vancomycin and Clarithromycin Show Synergy against <i>Mycobacterium abscessus In Vitro</i>.

Mukherjee Devika D   Wu Mu-Lu ML   Teo Jeanette W P JWP   Dick Thomas T  

Antimicrobial agents and chemotherapy 20171122 12


Lung disease caused by <i>Mycobacterium abscessus</i> is increasing, and current clarithromycin-based treatment regimens are only moderately effective. Here, we determined the effect of clarithromycin-vancomycin combination against <i>M. abscessus</i> complex isolates <i>in vitro</i> Synergy was found with a fractional inhibitory concentration index (FICI) score of ≤0.5 and a 4- to 10-fold decrease in MIC. ...[more]

Similar Datasets

| S-EPMC8693020 | biostudies-literature
| S-EPMC8592419 | biostudies-literature
| S-EPMC4576034 | biostudies-literature
| S-EPMC6105836 | biostudies-other
| S-EPMC5192163 | biostudies-literature
| S-EPMC6325232 | biostudies-literature
| S-EPMC4598034 | biostudies-literature
| S-EPMC7778363 | biostudies-literature
| S-EPMC8555507 | biostudies-literature
| S-EPMC10494244 | biostudies-literature